Genomic and immune profiling of prognostic risk groups in IgM gammopathy reveals novel biomarkers beyond MYD88 L265P.

Moreno DF, Nadeu F, Brasó-Maristany F, Vaqué S, Paz S, Mañé J, Cardús O, Medina E, Lozano E, Rodríguez-Lobato LG, de Daniel A, Tovar N, Cibeira MT, Bladé J, Rosiñol L, Prat A, Colomer D, Fernández de Larrea C

Open source

DOI: 10.3389/fimmu.2025.1604089
Published: 2025
Container: Frontiers in immunology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2025.1604089,
  title = {Genomic and immune profiling of prognostic risk groups in IgM gammopathy reveals novel biomarkers beyond MYD88 L265P.},
  author = {Moreno DF and Nadeu F and Brasó-Maristany F and Vaqué S and Paz S and Mañé J and Cardús O and Medina E and Lozano E and Rodríguez-Lobato LG and de Daniel A and Tovar N and Cibeira MT and Bladé J and Rosiñol L and Prat A and Colomer D and Fernández de Larrea C},
  year = {2025},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2025.1604089},
  url = {https://doi.org/10.3389/fimmu.2025.1604089}
}

RIS

TY  - JOUR
TI  - Genomic and immune profiling of prognostic risk groups in IgM gammopathy reveals novel biomarkers beyond MYD88 L265P.
AU  - Moreno DF
AU  - Nadeu F
AU  - Brasó-Maristany F
AU  - Vaqué S
AU  - Paz S
AU  - Mañé J
AU  - Cardús O
AU  - Medina E
AU  - Lozano E
AU  - Rodríguez-Lobato LG
AU  - de Daniel A
AU  - Tovar N
AU  - Cibeira MT
AU  - Bladé J
AU  - Rosiñol L
AU  - Prat A
AU  - Colomer D
AU  - Fernández de Larrea C
PY  - 2025
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2025.1604089
UR  - https://doi.org/10.3389/fimmu.2025.1604089
ER  -

APA

DF, M., F, N., F, B., S, V., S, P., J, M., O, C., E, M., E, L., LG, R., A, D. D., N, T., MT, C., J, B., L, R., A, P., D, C., & C, F. D. L. (2025). Genomic and immune profiling of prognostic risk groups in IgM gammopathy reveals novel biomarkers beyond MYD88 L265P.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2025.1604089

Source records

pubmed · retrieved 2026-09-25T20:24:36.427Z